Lessons from Failure: Stories of Resilience from Corporate Leaders Corporate Cultures
Corporate leaders often navigate turbulent waters where failure is not just a possibility but an inevitable part of the journey …
August 13, 2021: -The risk of suffering a breakthrough COVID-19 infection with the delta variant after being fully vaccinated with the Moderna vaccine may be much less than the risk for those receiving the Pfizer vaccine, according to a new Mayo Clinic study that is waiting for a full review.
In July, the study found that in Florida, where COVID cases are at an all-time high and the delta variant is prevalent, the breakthrough case risk was nearly 60% lower for Moderna recipients than Pfizer recipients.
Similarly, in Minnesota, the authors found that the Moderna vaccine was 76% effective in preventing infection, but the Pfizer vaccine (known as BNT162b2) was effective by 42%.
“Comparing rates of the infection amid matched individuals fully vaccinated with mRNA-1273 versus BNT162b2 across Mayo Clinic Health System sites in multiple states, -1273 conferred a two-fold risk reduction against breakthrough infection compared to BNT162b2,” the authors wrote in their abstract.
To be sure, the authors found that both the vaccines “strongly protect” against severe disease; the difference appears to be about whether people get infected at all in the first place. The CDC has said the risk of infection is 8x higher in the unvaccinated than the people who are vaccinated, and the risk of hospitalization or death is 25x higher.
On Sunday, the pre-print study was first released, which has not gone through a peer review or been published in an academic journal. However, it gained more notice when Axios reported that the Biden administration took the data as a “wake-up call.”
Pfizer told Axios that it and partner BioNTech “expect to be able to develop and produce a tailor-made vaccine against that variant in approximately 100 days after a decision to do so, subject to regulatory approval.”
In a subsequent statement, the company affirmed the effectiveness of its vaccines and said it was committed to developing boosters as well.
The previous week, Moderna warned that breakthrough infections were rising and said those who received its vaccine would likely need a booster dose before winter. And late last month, Pfizer said a booster in testing would be effective against the delta variant.
Data from New Jersey, the delta now accounts for 90% of all positive COVID samples tested. This week underscores the key points: Breakthrough infections still account for a tiny share of new COVID hospitalizations, but that share has increased significantly in the last few weeks.
Fully vaccinated New Jerseyans accounted for 18.5% of all new COVID cases on July 20-26.
Pfizer accounts for 30% of over 10.6 million vaccine doses administered in New Jersey to date, while Moderna accounts for nearly 21%, state data shows.
Corporate leaders often navigate turbulent waters where failure is not just a possibility but an inevitable part of the journey …
Corporate leaders play a pivotal role in shaping organizational cultures that embrace diversity and foster inclusivity. How can these …
Corporate leaders occupy a unique vantage point in the business world, offering insights and guidance shaped by their …
Corporate leaders today stand at the nexus of unprecedented technological evolution, where digital transformation reshapes industries and redefines …
Corporate leaders stand at the helm of their organizations, often tasked with making decisions that can steer their companies toward …
Corporate leaders are often tested by crises that threaten the very foundation of their organizations. How do these leaders navigate turbulent …
Shares of Lululemon Athletica Inc. experienced a significant surge after the company reported strong quarterly earnings driven by robust international …
Systems thinking is an approach that focuses on understanding how different parts of a system interact and influence one another within a whole. It is a holistic framework considering interrelationships and patterns rather than static snapshots. By expanding perspectives, systems thinking clarifies complex situations and can spur innovation.
A definite ‘NO’ to the question if struggling families had child care asked by a group of committed volunteers in the San Fernando Valley in 1974, urged the volunteers to look for a way to support families struggling to find quality child care, development, and education services for their families. That year, the San Fernando Valley Child Care Consortium and the Mayor’s Child Care and Junior Task Force proposed the first child care resource center in the San Fernando Valley. Doris McLain was elected chairperson as Mayor Bradley accepted the proposal and gave the newly founded Child Care Resource Center (CCRC) space in Van Nuys City Hall Center. CCRC began 45 years to help working moms find child care.
Dr. Louis B. Lynn, President and Founder of ENVIRO Ag Science, grew up in Darlington County South Carolina before graduating from Clemson University. He has been a member of the Clemson University Board of Trustees since 1988 and takes pride in having attended almost all the 96 Graduation Ceremonies that have occurred during his board tenure. He hasalso served as Adjunct Professor of Horticulture at Clemson. Dr. Lynn also currently serves on the Board of Trustees of the NYC headquarters of the National Urban League. Dr. Lynn is a retired Corporate Bank Director of BB&T now TRUIST Financial (NYSE – TFC). Dr. Lynn formerly served as a national board member of the American Horticulture Society; a national board member of the National Association of Minority Contractors, a two-term Commissioner for the SCCommission on Higher Education; a Commissioner forthe StateWorkforce Development Board.
Leave us a message
Subscribe
Fill the form our team will contact you
Advertise with us
Fill the form our team will contact you